|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02192 MEDLIVE
Nominal 
6.790 -0.064 (-0.934%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 315,200 | 1.014% | 642,155 | 558,455 | 412,004 | 314,054 |
| Cost of Sales | (121,067) | -5.481% | (256,715) | (231,233) | (160,669) | (101,313) |
| Gross Profit | 194,133 | 5.537% | 385,440 | 327,222 | 251,335 | 212,741 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 5 | 12 | |
| Profit / (Loss) before Taxation | 178,113 | 6.990% | 360,288 | 340,474 | 253,132 | 135,037 | |
| Taxation | (10,304) | 69.725% | (12,399) | (10,173) | (1,372) | (8,616) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (6,269) | 23.698% | (13,548) | (15,155) | (9,459) | (9,100) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 161,540 | 3.993% | 334,341 | 315,146 | 242,301 | 117,321 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (83,561) | -10.900% | (177,039) | (203,933) | (183,523) | (65,711) |
| Depreciation & Amortisation | -- | -- | 21,087 | 15,600 | 9,371 | 8,987 |
| Directors' Emoluments | -- | -- | 7,723 | 9,171 | 10,048 | 13,372 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 21.870 | 3.160% | 45.600 | 43.230 | 33.560 | 16.420 |
| DPS (cts) | 13.090 | -- | 26.010 | 25.710 | 23.150 | 6.540 |
| Dividend Payout Ratio (%) | 59.854% | -- | 57.039% | 59.473% | 68.981% | 39.829% |
| Cash flow per share ($) | -- | -- | 0.183 | 0.149 | 0.141 | 0.108 |
| NBV per share ($) | 6.485 | -- | 6.599 | 6.548 | 6.324 | 6.135 |
| Remarks: | Real time quote last updated: 10/09/2026 12:30 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 161,540 |
| %Change | 3.993% |
| EPS / (LPS) | RMB 0.219 |
| NBV Per Share (¥) | RMB 6.485 |